Aura Biosciences (AURA) Stock Price & Analysis

AURA$7.110.00 0.00%
BiotechnologyGrowth Stock
Compare
Market cap$739.97MEnterprise value$767.84MRevenue (TTM)$0Market position—

Score

67
Bullish
Value
53
Quality
48
Growth
100

AI Analysis

Snapshot

Aura Biosciences is a growth-led story right now — Growth 100/100 is the pillar doing the heavy lifting (overall 67/100) in Biotechnology. In Biotechnology, that score mix is usable but not one-dimensional. Street targets still imply ~146% upside.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

53
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

100
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

48
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Aura Biosciences, Inc. (AURA) last printed $7.11. Equity value is $739.97M. Trailing earnings multiple —. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2019202020212022202320242025
$0.00$0.00$0.00$0.00$0.00$0.00$0.00

About

Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary virus-like drug conjugate (VDC) technology platform to address tumors with significant unmet medical needs, specifically in ocular (eye) and urologic oncology. Its flagship therapeutic candidate, AU-011, is a VDC currently in development for the treatment of primary choroidal melanoma. Furthermore, Aura Biosciences is investigating AU-011's potential for other ocular oncology applications, such as choroidal metastases.

Aura Biosciences (AURA) Stock Price & Analysis

AURA price $7.11 0.00 0.00%

Ticker
AURA
Price
$7.11
Change
0.00 0.00%
Market cap
$739.97M
Dividend yield
0.00%
Beta
0.41
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
67
Value
53
Quality
48
Growth
100

Stocklytics score rationale: value 53, quality 48, growth 100.

Fair value

AURA fair value Not meaningful. Price $7.11.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price.

Fair value is the earnings value from next-twelve-months EPS times 28.4, a blend of the industry median and the stock's own 10-year median. A cash-flow value is not available for this stock. How we calculate it →

Not meaningful. The model is more than 80% below the live price, which happens for unprofitable or very early companies and is not a price target.

Compare AURA

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2027-03-30—-0.30——
2027-03-29—-0.33——
2026-11-09-0.29-0.37——
2026-08-11-0.48-0.38——
2026-05-11-0.50-0.40——
2026-03-30-0.37-0.43——
2025-11-13-0.40-0.46——
2025-08-13-0.47-0.49——
2025-05-15-0.55-0.47——
2025-03-24-0.52-0.43——
2024-11-12-0.42-0.44——
2024-08-08-0.41-0.45——
2024-05-09-0.40-0.51——
2024-03-27-0.50-0.392.06M—
2023-11-09-0.48-0.54——
2023-08-09-0.48-0.49——
2023-05-11-0.46-0.52——
2023-03-15-0.52-0.58——
2022-11-10-0.53-0.52——
2022-08-11-0.46-0.46——
2022-05-12-0.44-0.44——
2022-03-23-2.51-0.39——
2021-11-24-0.32———
2021-11-01-0.45———
2021-03-31-0.30———
2020-12-31-0.25———
2020-09-30-0.19———
2020-06-30-0.22———
2020-03-31-0.27———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-01Person JulieBuy212.39K$7.431.58M
2026-09-01Person JulieBuy107.61K——
2026-09-01Kratz EricaBuy199.12K$7.431.48M
2026-09-01Kratz EricaBuy100.89K——
2026-09-01Hopkins Janet JillBuy58.85K——
2026-09-01Hopkins Janet JillBuy116.15K$7.43862.99K
2026-09-01Elazzouzi AmyBuy23.54K——
2026-09-01Elazzouzi AmyBuy46.46K$7.43345.20K
2026-09-01Abu-Absi SusanBuy265.49K$7.431.97M
2026-09-01Abu-Absi SusanBuy134.51K——
2026-08-12Person JulieOther0——
2026-08-10Kratz EricaOther0——
2026-08-10Abu-Absi SusanOther0——
2026-07-07Bender JeremyBuy60.00K$7.03421.80K
2026-07-07Bender JeremyBuy30.00K——
2026-07-07Bender JeremyOther0——
2026-07-01Kilroy ConorBuy14.86K——
2026-06-16Gibney Anthony SSell12.82K$6.4282.33K
2026-06-11Bitetti Teresa MarieBuy15.00K——
2026-06-11Bitetti Teresa MarieBuy30.00K$6.21186.30K
2026-06-11Srivastava SapnaBuy15.00K——
2026-06-11Srivastava SapnaBuy30.00K$6.21186.30K
2026-06-11Johnson David MichaelBuy15.00K——
2026-06-11Johnson David MichaelBuy30.00K$6.21186.30K
2026-06-11Mattessich Antony C.Buy15.00K——
2026-06-11Mattessich Antony C.Buy30.00K$6.21186.30K
2026-05-19Holles Natalie C.Buy2.17M$7.3916.03M
2026-05-19Holles Natalie C.Buy553.84K——
2026-05-19Holles Natalie C.Buy600.12K——
2026-05-07Matrix Capital Management Company, LPSell6.92M$5.6439.04M
2026-04-30Holles Natalie C.Other0——
2026-04-16Kilroy ConorSell11.74K$7.0282.40K
2026-03-02Kilroy ConorBuy62.34K——
2026-03-02Kilroy ConorBuy112.66K$6.14691.74K
2026-03-02Gibney Anthony SBuy71.25K——
2026-03-02Gibney Anthony SBuy128.75K$6.14790.56K
2026-03-02de los Pinos ElisabetBuy166.00K——
2026-03-02de los Pinos ElisabetBuy249.00K$6.141.53M
2026-03-02Plavsic MarkBuy62.34K——
2026-03-02Plavsic MarkBuy112.66K$6.14691.74K
2026-03-02Hopkins Janet JillBuy89.06K——
2026-03-02Hopkins Janet JillBuy160.94K$6.14988.20K
2026-03-02Elazzouzi AmyBuy44.53K——
2026-03-02Elazzouzi AmyBuy80.47K$6.14494.10K
2026-02-17Kilroy ConorSell12.08K$5.0561.00K
2026-02-17Plavsic MarkSell15.89K$5.0580.24K
2026-02-17Hopkins Janet JillSell20.40K$5.06103.23K
2026-02-17Elazzouzi AmySell8.55K$5.0643.26K
2026-02-17de los Pinos ElisabetSell47.65K$5.06241.10K
2026-01-20Elazzouzi AmySell1.58K$4.867.68K
2026-01-20de los Pinos ElisabetSell16.93K$4.8682.27K
2025-11-17Hopkins Janet JillSell17.11K$5.4292.73K
2025-10-29Elazzouzi AmySell896$6.355.69K
2025-10-29de los Pinos ElisabetSell9.05K$6.3557.46K
2025-10-16Plavsic MarkSell12.17K$6.3577.27K
2025-08-18Elazzouzi AmyBuy2.32K$4.259.86K
2025-08-18Elazzouzi AmyBuy1.09K$3.163.46K
2025-08-18Elazzouzi AmyBuy4.74K$2.7413.00K
2025-08-18Elazzouzi AmySell7.72K$6.7051.74K
2025-08-18Elazzouzi AmyBuy547$5.212.85K
2025-08-18Elazzouzi AmyBuy547$5.483.00K
2025-08-18Elazzouzi AmyBuy1.09K$5.486.00K
2025-08-18Elazzouzi AmyBuy2.55K$5.0712.95K
2025-08-18Elazzouzi AmySell4.74K$2.7413.00K
2025-08-18Elazzouzi AmySell1.09K$3.163.46K
2025-08-18Elazzouzi AmySell2.32K$4.259.86K
2025-08-18Elazzouzi AmySell2.55K$5.0712.95K
2025-08-18Elazzouzi AmySell547$5.212.85K
2025-08-18Elazzouzi AmySell547$5.483.00K
2025-06-17Srivastava SapnaBuy13.00K——
2025-06-17Srivastava SapnaBuy17.00K$6.18105.06K
2025-06-17Johnson David MichaelBuy13.00K——
2025-06-17Johnson David MichaelBuy17.00K$6.18105.06K
2025-06-17Mattessich Antony C.Buy13.00K——
2025-06-17Mattessich Antony C.Buy17.00K$6.18105.06K
2025-06-02Gibney Anthony SBuy250.00K$6.161.54M
2025-06-02Gibney Anthony SBuy150.00K——
2025-06-02de los Pinos ElisabetBuy10.95K$5.0755.51K
2025-06-02de los Pinos ElisabetSell9.95K$6.1661.28K
2025-06-02de los Pinos ElisabetSell10.95K$5.0755.51K
2025-05-16Johnson David MichaelBuy20.00K$4.9098.00K
2025-05-16Johnson David MichaelBuy5.00K$4.9024.50K
2025-05-16Gibney Anthony SBuy50.00K$4.90245.00K
2025-05-16Gibney Anthony SSell1.52K$5.157.82K
2025-05-16Gibney Anthony SBuy12.50K$4.9061.25K
2025-05-13Gibney Anthony SOther0——
2025-05-13Gibney Anthony SOther0$7.210
2025-04-16Elazzouzi AmySell897$5.494.92K
2025-04-16Kilroy ConorSell7.16K$5.4939.32K
2025-03-31Bitetti Teresa MarieBuy29.00K$5.86169.94K
2025-03-31Bitetti Teresa MarieBuy21.00K——
2025-03-31Bitetti Teresa MarieOther0——
2025-02-18Plavsic MarkSell2.15K$7.7516.67K
2025-02-18Elazzouzi AmySell1.40K$7.7510.88K
2025-02-18Hopkins Janet JillSell2.53K$7.7519.64K
2025-02-18de los Pinos ElisabetSell20.22K$7.75156.80K
2025-02-03de los Pinos ElisabetBuy194.32K——
2025-02-03de los Pinos ElisabetBuy255.68K$7.681.96M
2025-02-03Plavsic MarkBuy90.47K——
2025-02-03Plavsic MarkBuy59.52K$7.68457.15K

Institutional holders

Latest filed quarter: Q3 2026.

Institutions holding: 98, holders -53 vs prior quarter. Ownership 32.85%.

HolderSharesChangeChange %Value
BLACKROCK, INC.5.42M716.59K+15.22%34.06M
VANGUARD CAPITAL MANAGEMENT LLC3.95M-148.02K-3.61%24.82M
NANTAHALA CAPITAL MANAGEMENT, LLC3.81M856.27K+29.02%23.91M
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD3.04M00.00%19.09M
STATE STREET CORP2.30M1.08M+88.19%14.45M
FRANKLIN TEMPLETON INC2.08M9.56K+0.46%13.85M
GEODE CAPITAL MANAGEMENT, LLC1.94M190.02K+10.83%12.22M
VIVO CAPITAL, LLC1.17M00.00%7.33M
VANGUARD PORTFOLIO MANAGEMENT LLC942.72K71.38K+8.19%5.92M
LEVIN CAPITAL STRATEGIES, L.P.826.83K-11.23K-1.34%5.19M
DIMENSIONAL FUND ADVISORS LP708.95K90.06K+14.55%4.45M
VANGUARD FIDUCIARY TRUST CO633.16K-4.04K-0.63%3.98M
REGENCY CAPITAL MANAGEMENT INC.\DE533.07K-7.33K-1.36%3.35M
FMR LLC384.00K128.66K+50.39%2.41M
QUBE RESEARCH & TECHNOLOGIES LTD272.14K272.14KNew1.71M
HRT FINANCIAL LP266.72K266.72KNew1.68M
JUMP FINANCIAL, LLC218.93K218.93KNew1.37M
QUANTINNO CAPITAL MANAGEMENT LP216.92K86.26K+66.02%1.36M
MORGAN STANLEY196.81K22.12K+12.66%1.24M
Y-INTERCEPT (HONG KONG) LTD174.12K174.12KNew1.09M
BNP PARIBAS FINANCIAL MARKETS142.57K142.57KNew895.37K
RENAISSANCE TECHNOLOGIES LLC140.08K-34.12K-19.58%879.73K
BANK OF NEW YORK MELLON CORP138.06K19.46K+16.41%866.99K
UBS GROUP AG102.92K102.92KNew646.33K
NUVEEN, LLC100.72K100.72KNew632.49K

Insights · Forecast · Financials · Learn

Stocklytics home · Screener